Global Oncology Injection Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Oncology Injection Drug market size was valued at US$ 179 million in 2024 and is forecast to a readjusted size of USD 262 million by 2031 with a CAGR of 5.7% during review period.
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Oncology Injection Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology Injection Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Oncology Injection Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Oncology Injection Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Oncology Injection Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Injection Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Injection Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme, Eli Lilly, Praecis Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oncology Injection Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Injection Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncology Injection Drug, with price, sales quantity, revenue, and global market share of Oncology Injection Drug from 2020 to 2025.
Chapter 3, the Oncology Injection Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Injection Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Oncology Injection Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology Injection Drug.
Chapter 14 and 15, to describe Oncology Injection Drug sales channel, distributors, customers, research findings and conclusion.
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Oncology Injection Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oncology Injection Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Oncology Injection Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Oncology Injection Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Oncology Injection Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oncology Injection Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oncology Injection Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Taj Oncology, S.G. Biopharm, AdvaCare, Merrimack, Celgene, Allos Therapeutics, Ferring Pharmaceuticals, Genzyme, Eli Lilly, Praecis Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oncology Injection Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Organs
- Central Nervous System
- Circulatory/Musculoskeletal System
- Other
- Lymphoma
- Myeloma
- Prostate Cancer
- Other
- Taj Oncology
- S.G. Biopharm
- AdvaCare
- Merrimack
- Celgene
- Allos Therapeutics
- Ferring Pharmaceuticals
- Genzyme
- Eli Lilly
- Praecis Pharmaceuticals
- Millennium Pharmaceuticals
- Debiopharm
- Alza
- CordenPharma
- Pharmascience
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Injection Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncology Injection Drug, with price, sales quantity, revenue, and global market share of Oncology Injection Drug from 2020 to 2025.
Chapter 3, the Oncology Injection Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Injection Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Oncology Injection Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology Injection Drug.
Chapter 14 and 15, to describe Oncology Injection Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncology Injection Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Organs
1.3.3 Central Nervous System
1.3.4 Circulatory/Musculoskeletal System
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncology Injection Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Lymphoma
1.4.3 Myeloma
1.4.4 Prostate Cancer
1.4.5 Other
1.5 Global Oncology Injection Drug Market Size & Forecast
1.5.1 Global Oncology Injection Drug Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Oncology Injection Drug Sales Quantity (2020-2031)
1.5.3 Global Oncology Injection Drug Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Taj Oncology
2.1.1 Taj Oncology Details
2.1.2 Taj Oncology Major Business
2.1.3 Taj Oncology Oncology Injection Drug Product and Services
2.1.4 Taj Oncology Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Taj Oncology Recent Developments/Updates
2.2 S.G. Biopharm
2.2.1 S.G. Biopharm Details
2.2.2 S.G. Biopharm Major Business
2.2.3 S.G. Biopharm Oncology Injection Drug Product and Services
2.2.4 S.G. Biopharm Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 S.G. Biopharm Recent Developments/Updates
2.3 AdvaCare
2.3.1 AdvaCare Details
2.3.2 AdvaCare Major Business
2.3.3 AdvaCare Oncology Injection Drug Product and Services
2.3.4 AdvaCare Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 AdvaCare Recent Developments/Updates
2.4 Merrimack
2.4.1 Merrimack Details
2.4.2 Merrimack Major Business
2.4.3 Merrimack Oncology Injection Drug Product and Services
2.4.4 Merrimack Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merrimack Recent Developments/Updates
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Oncology Injection Drug Product and Services
2.5.4 Celgene Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Celgene Recent Developments/Updates
2.6 Allos Therapeutics
2.6.1 Allos Therapeutics Details
2.6.2 Allos Therapeutics Major Business
2.6.3 Allos Therapeutics Oncology Injection Drug Product and Services
2.6.4 Allos Therapeutics Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Allos Therapeutics Recent Developments/Updates
2.7 Ferring Pharmaceuticals
2.7.1 Ferring Pharmaceuticals Details
2.7.2 Ferring Pharmaceuticals Major Business
2.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product and Services
2.7.4 Ferring Pharmaceuticals Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Ferring Pharmaceuticals Recent Developments/Updates
2.8 Genzyme
2.8.1 Genzyme Details
2.8.2 Genzyme Major Business
2.8.3 Genzyme Oncology Injection Drug Product and Services
2.8.4 Genzyme Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Genzyme Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Oncology Injection Drug Product and Services
2.9.4 Eli Lilly Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Praecis Pharmaceuticals
2.10.1 Praecis Pharmaceuticals Details
2.10.2 Praecis Pharmaceuticals Major Business
2.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product and Services
2.10.4 Praecis Pharmaceuticals Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Praecis Pharmaceuticals Recent Developments/Updates
2.11 Millennium Pharmaceuticals
2.11.1 Millennium Pharmaceuticals Details
2.11.2 Millennium Pharmaceuticals Major Business
2.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product and Services
2.11.4 Millennium Pharmaceuticals Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Millennium Pharmaceuticals Recent Developments/Updates
2.12 Debiopharm
2.12.1 Debiopharm Details
2.12.2 Debiopharm Major Business
2.12.3 Debiopharm Oncology Injection Drug Product and Services
2.12.4 Debiopharm Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Debiopharm Recent Developments/Updates
2.13 Alza
2.13.1 Alza Details
2.13.2 Alza Major Business
2.13.3 Alza Oncology Injection Drug Product and Services
2.13.4 Alza Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Alza Recent Developments/Updates
2.14 CordenPharma
2.14.1 CordenPharma Details
2.14.2 CordenPharma Major Business
2.14.3 CordenPharma Oncology Injection Drug Product and Services
2.14.4 CordenPharma Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 CordenPharma Recent Developments/Updates
2.15 Pharmascience
2.15.1 Pharmascience Details
2.15.2 Pharmascience Major Business
2.15.3 Pharmascience Oncology Injection Drug Product and Services
2.15.4 Pharmascience Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Pharmascience Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ONCOLOGY INJECTION DRUG BY MANUFACTURER
3.1 Global Oncology Injection Drug Sales Quantity by Manufacturer (2020-2025)
3.2 Global Oncology Injection Drug Revenue by Manufacturer (2020-2025)
3.3 Global Oncology Injection Drug Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Oncology Injection Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Oncology Injection Drug Manufacturer Market Share in 2024
3.4.3 Top 6 Oncology Injection Drug Manufacturer Market Share in 2024
3.5 Oncology Injection Drug Market: Overall Company Footprint Analysis
3.5.1 Oncology Injection Drug Market: Region Footprint
3.5.2 Oncology Injection Drug Market: Company Product Type Footprint
3.5.3 Oncology Injection Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oncology Injection Drug Market Size by Region
4.1.1 Global Oncology Injection Drug Sales Quantity by Region (2020-2031)
4.1.2 Global Oncology Injection Drug Consumption Value by Region (2020-2031)
4.1.3 Global Oncology Injection Drug Average Price by Region (2020-2031)
4.2 North America Oncology Injection Drug Consumption Value (2020-2031)
4.3 Europe Oncology Injection Drug Consumption Value (2020-2031)
4.4 Asia-Pacific Oncology Injection Drug Consumption Value (2020-2031)
4.5 South America Oncology Injection Drug Consumption Value (2020-2031)
4.6 Middle East & Africa Oncology Injection Drug Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Oncology Injection Drug Sales Quantity by Type (2020-2031)
5.2 Global Oncology Injection Drug Consumption Value by Type (2020-2031)
5.3 Global Oncology Injection Drug Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oncology Injection Drug Sales Quantity by Application (2020-2031)
6.2 Global Oncology Injection Drug Consumption Value by Application (2020-2031)
6.3 Global Oncology Injection Drug Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Oncology Injection Drug Sales Quantity by Type (2020-2031)
7.2 North America Oncology Injection Drug Sales Quantity by Application (2020-2031)
7.3 North America Oncology Injection Drug Market Size by Country
7.3.1 North America Oncology Injection Drug Sales Quantity by Country (2020-2031)
7.3.2 North America Oncology Injection Drug Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Oncology Injection Drug Sales Quantity by Type (2020-2031)
8.2 Europe Oncology Injection Drug Sales Quantity by Application (2020-2031)
8.3 Europe Oncology Injection Drug Market Size by Country
8.3.1 Europe Oncology Injection Drug Sales Quantity by Country (2020-2031)
8.3.2 Europe Oncology Injection Drug Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncology Injection Drug Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Oncology Injection Drug Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Oncology Injection Drug Market Size by Region
9.3.1 Asia-Pacific Oncology Injection Drug Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Oncology Injection Drug Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Oncology Injection Drug Sales Quantity by Type (2020-2031)
10.2 South America Oncology Injection Drug Sales Quantity by Application (2020-2031)
10.3 South America Oncology Injection Drug Market Size by Country
10.3.1 South America Oncology Injection Drug Sales Quantity by Country (2020-2031)
10.3.2 South America Oncology Injection Drug Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncology Injection Drug Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Oncology Injection Drug Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Oncology Injection Drug Market Size by Country
11.3.1 Middle East & Africa Oncology Injection Drug Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Oncology Injection Drug Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Oncology Injection Drug Market Drivers
12.2 Oncology Injection Drug Market Restraints
12.3 Oncology Injection Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oncology Injection Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncology Injection Drug
13.3 Oncology Injection Drug Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncology Injection Drug Typical Distributors
14.3 Oncology Injection Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Oncology Injection Drug Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oncology Injection Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3.Taj Oncology Basic Information, Manufacturing Base and Competitors
Table 4.Taj Oncology Major Business
Table 5.Taj Oncology Oncology Injection Drug Product and Services
Table 6.Taj Oncology Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7.Taj Oncology Recent Developments/Updates
Table 8. S.G. Biopharm Basic Information, Manufacturing Base and Competitors
Table 9. S.G. Biopharm Major Business
Table 10. S.G. Biopharm Oncology Injection Drug Product and Services
Table 11. S.G. Biopharm Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. S.G. Biopharm Recent Developments/Updates
Table 13. AdvaCare Basic Information, Manufacturing Base and Competitors
Table 14. AdvaCare Major Business
Table 15. AdvaCare Oncology Injection Drug Product and Services
Table 16. AdvaCare Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. AdvaCare Recent Developments/Updates
Table 18. Merrimack Basic Information, Manufacturing Base and Competitors
Table 19. Merrimack Major Business
Table 20. Merrimack Oncology Injection Drug Product and Services
Table 21. Merrimack Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merrimack Recent Developments/Updates
Table 23. Celgene Basic Information, Manufacturing Base and Competitors
Table 24. Celgene Major Business
Table 25. Celgene Oncology Injection Drug Product and Services
Table 26. Celgene Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Celgene Recent Developments/Updates
Table 28. AllosTherapeutics Basic Information, Manufacturing Base and Competitors
Table 29. AllosTherapeutics Major Business
Table 30. AllosTherapeutics Oncology Injection Drug Product and Services
Table 31. AllosTherapeutics Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. AllosTherapeutics Recent Developments/Updates
Table 33.Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34.Ferring Pharmaceuticals Major Business
Table 35.Ferring Pharmaceuticals Oncology Injection Drug Product and Services
Table 36.Ferring Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37.Ferring Pharmaceuticals Recent Developments/Updates
Table 38. Genzyme Basic Information, Manufacturing Base and Competitors
Table 39. Genzyme Major Business
Table 40. Genzyme Oncology Injection Drug Product and Services
Table 41. Genzyme Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Genzyme Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Oncology Injection Drug Product and Services
Table 46. Eli Lilly Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Praecis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Praecis Pharmaceuticals Major Business
Table 50. Praecis Pharmaceuticals Oncology Injection Drug Product and Services
Table 51. Praecis Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Praecis Pharmaceuticals Recent Developments/Updates
Table 53. Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Millennium Pharmaceuticals Major Business
Table 55. Millennium Pharmaceuticals Oncology Injection Drug Product and Services
Table 56. Millennium Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Millennium Pharmaceuticals Recent Developments/Updates
Table 58. Debiopharm Basic Information, Manufacturing Base and Competitors
Table 59. Debiopharm Major Business
Table 60. Debiopharm Oncology Injection Drug Product and Services
Table 61. Debiopharm Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Debiopharm Recent Developments/Updates
Table 63. Alza Basic Information, Manufacturing Base and Competitors
Table 64. Alza Major Business
Table 65. Alza Oncology Injection Drug Product and Services
Table 66. Alza Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Alza Recent Developments/Updates
Table 68. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 69. CordenPharma Major Business
Table 70. CordenPharma Oncology Injection Drug Product and Services
Table 71. CordenPharma Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. CordenPharma Recent Developments/Updates
Table 73. Pharmascience Basic Information, Manufacturing Base and Competitors
Table 74. Pharmascience Major Business
Table 75. Pharmascience Oncology Injection Drug Product and Services
Table 76. Pharmascience Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Pharmascience Recent Developments/Updates
Table 78. Global Oncology Injection Drug Sales Quantity by Manufacturer (2020-2025) & (K Pcs)
Table 79. Global Oncology Injection Drug Revenue by Manufacturer (2020-2025) & (USD Million)
Table 80. Global Oncology Injection Drug Average Price by Manufacturer (2020-2025) & (USD/Pcs)
Table 81. Market Position of Manufacturers in Oncology Injection Drug, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 82. Head Office and Oncology Injection Drug Production Site of Key Manufacturer
Table 83. Oncology Injection Drug Market: Company ProductTypeFootprint
Table 84. Oncology Injection Drug Market: Company Product ApplicationFootprint
Table 85. Oncology Injection Drug New Market Entrants and Barriers to Market Entry
Table 86. Oncology Injection Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Oncology Injection Drug Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 88. Global Oncology Injection Drug Sales Quantity by Region (2020-2025) & (K Pcs)
Table 89. Global Oncology Injection Drug Sales Quantity by Region (2026-2031) & (K Pcs)
Table 90. Global Oncology Injection Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 91. Global Oncology Injection Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 92. Global Oncology Injection Drug Average Price by Region (2020-2025) & (USD/Pcs)
Table 93. Global Oncology Injection Drug Average Price by Region (2026-2031) & (USD/Pcs)
Table 94. Global Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 95. Global Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 96. Global Oncology Injection Drug Consumption Value byType (2020-2025) & (USD Million)
Table 97. Global Oncology Injection Drug Consumption Value byType (2026-2031) & (USD Million)
Table 98. Global Oncology Injection Drug Average Price byType (2020-2025) & (USD/Pcs)
Table 99. Global Oncology Injection Drug Average Price byType (2026-2031) & (USD/Pcs)
Table 100. Global Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 101. Global Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 102. Global Oncology Injection Drug Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Global Oncology Injection Drug Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Global Oncology Injection Drug Average Price by Application (2020-2025) & (USD/Pcs)
Table 105. Global Oncology Injection Drug Average Price by Application (2026-2031) & (USD/Pcs)
Table 106. North America Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 107. North America Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 108. North America Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 109. North America Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 110. North America Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 111. North America Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 112. North America Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 115. Europe Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 116. Europe Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 117. Europe Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 118. Europe Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 119. Europe Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 120. Europe Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 121. Europe Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Asia-Pacific Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 123. Asia-Pacific Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 124. Asia-Pacific Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 125. Asia-Pacific Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 126. Asia-Pacific Oncology Injection Drug Sales Quantity by Region (2020-2025) & (K Pcs)
Table 127. Asia-Pacific Oncology Injection Drug Sales Quantity by Region (2026-2031) & (K Pcs)
Table 128. Asia-Pacific Oncology Injection Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 129. Asia-Pacific Oncology Injection Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 130. South America Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 131. South America Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 132. South America Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 133. South America Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 134. South America Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 135. South America Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 136. South America Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 137. South America Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Middle East & Africa Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 139. Middle East & Africa Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 140. Middle East & Africa Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 141. Middle East & Africa Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 142. Middle East & Africa Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 143. Middle East & Africa Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 144. Middle East & Africa Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 145. Middle East & Africa Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 146. Oncology Injection Drug Raw Material
Table 147. Key Manufacturers of Oncology Injection Drug Raw Materials
Table 148. Oncology Injection DrugTypical Distributors
Table 149. Oncology Injection DrugTypical Customers
LIST OFFIGURES
Figure 1. Oncology Injection Drug Picture
Figure 2. Global Oncology Injection Drug Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oncology Injection Drug Revenue Market Share byType in 2024
Figure 4. Organs Examples
Figure 5. Central Nervous System Examples
Figure 6. Circulatory/Musculoskeletal System Examples
Figure 7. Other Examples
Figure 8. Global Oncology Injection Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Oncology Injection Drug Revenue Market Share by Application in 2024
Figure 10. Lymphoma Examples
Figure 11. Myeloma Examples
Figure 12. Prostate Cancer Examples
Figure 13. Other Examples
Figure 14. Global Oncology Injection Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Oncology Injection Drug Consumption Value andForecast (2020-2031) & (USD Million)
Figure 16. Global Oncology Injection Drug Sales Quantity (2020-2031) & (K Pcs)
Figure 17. Global Oncology Injection Drug Price (2020-2031) & (USD/Pcs)
Figure 18. Global Oncology Injection Drug Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Oncology Injection Drug Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Oncology Injection Drug by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21.Top 3 Oncology Injection Drug Manufacturer (Revenue) Market Share in 2024
Figure 22.Top 6 Oncology Injection Drug Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Oncology Injection Drug Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Oncology Injection Drug Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 31. Global Oncology Injection Drug Consumption Value Market Share byType (2020-2031)
Figure 32. Global Oncology Injection Drug Average Price byType (2020-2031) & (USD/Pcs)
Figure 33. Global Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Oncology Injection Drug Revenue Market Share by Application (2020-2031)
Figure 35. Global Oncology Injection Drug Average Price by Application (2020-2031) & (USD/Pcs)
Figure 36. North America Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 37. North America Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 44. Europe Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 48.France Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 53. Asia-Pacific Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Oncology Injection Drug Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Oncology Injection Drug Consumption Value Market Share by Region (2020-2031)
Figure 56. China Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 59. India Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 63. South America Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 69. Middle East & Africa Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 72.Turkey Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 76. Oncology Injection Drug Market Drivers
Figure 77. Oncology Injection Drug Market Restraints
Figure 78. Oncology Injection Drug MarketTrends
Figure 79. PortersFiveForces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Oncology Injection Drug in 2024
Figure 81. Manufacturing Process Analysis of Oncology Injection Drug
Figure 82. Oncology Injection Drug Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncology Injection Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Organs
1.3.3 Central Nervous System
1.3.4 Circulatory/Musculoskeletal System
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncology Injection Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Lymphoma
1.4.3 Myeloma
1.4.4 Prostate Cancer
1.4.5 Other
1.5 Global Oncology Injection Drug Market Size & Forecast
1.5.1 Global Oncology Injection Drug Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Oncology Injection Drug Sales Quantity (2020-2031)
1.5.3 Global Oncology Injection Drug Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Taj Oncology
2.1.1 Taj Oncology Details
2.1.2 Taj Oncology Major Business
2.1.3 Taj Oncology Oncology Injection Drug Product and Services
2.1.4 Taj Oncology Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Taj Oncology Recent Developments/Updates
2.2 S.G. Biopharm
2.2.1 S.G. Biopharm Details
2.2.2 S.G. Biopharm Major Business
2.2.3 S.G. Biopharm Oncology Injection Drug Product and Services
2.2.4 S.G. Biopharm Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 S.G. Biopharm Recent Developments/Updates
2.3 AdvaCare
2.3.1 AdvaCare Details
2.3.2 AdvaCare Major Business
2.3.3 AdvaCare Oncology Injection Drug Product and Services
2.3.4 AdvaCare Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 AdvaCare Recent Developments/Updates
2.4 Merrimack
2.4.1 Merrimack Details
2.4.2 Merrimack Major Business
2.4.3 Merrimack Oncology Injection Drug Product and Services
2.4.4 Merrimack Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merrimack Recent Developments/Updates
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business
2.5.3 Celgene Oncology Injection Drug Product and Services
2.5.4 Celgene Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Celgene Recent Developments/Updates
2.6 Allos Therapeutics
2.6.1 Allos Therapeutics Details
2.6.2 Allos Therapeutics Major Business
2.6.3 Allos Therapeutics Oncology Injection Drug Product and Services
2.6.4 Allos Therapeutics Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Allos Therapeutics Recent Developments/Updates
2.7 Ferring Pharmaceuticals
2.7.1 Ferring Pharmaceuticals Details
2.7.2 Ferring Pharmaceuticals Major Business
2.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product and Services
2.7.4 Ferring Pharmaceuticals Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Ferring Pharmaceuticals Recent Developments/Updates
2.8 Genzyme
2.8.1 Genzyme Details
2.8.2 Genzyme Major Business
2.8.3 Genzyme Oncology Injection Drug Product and Services
2.8.4 Genzyme Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Genzyme Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Oncology Injection Drug Product and Services
2.9.4 Eli Lilly Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Praecis Pharmaceuticals
2.10.1 Praecis Pharmaceuticals Details
2.10.2 Praecis Pharmaceuticals Major Business
2.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product and Services
2.10.4 Praecis Pharmaceuticals Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Praecis Pharmaceuticals Recent Developments/Updates
2.11 Millennium Pharmaceuticals
2.11.1 Millennium Pharmaceuticals Details
2.11.2 Millennium Pharmaceuticals Major Business
2.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product and Services
2.11.4 Millennium Pharmaceuticals Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Millennium Pharmaceuticals Recent Developments/Updates
2.12 Debiopharm
2.12.1 Debiopharm Details
2.12.2 Debiopharm Major Business
2.12.3 Debiopharm Oncology Injection Drug Product and Services
2.12.4 Debiopharm Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Debiopharm Recent Developments/Updates
2.13 Alza
2.13.1 Alza Details
2.13.2 Alza Major Business
2.13.3 Alza Oncology Injection Drug Product and Services
2.13.4 Alza Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Alza Recent Developments/Updates
2.14 CordenPharma
2.14.1 CordenPharma Details
2.14.2 CordenPharma Major Business
2.14.3 CordenPharma Oncology Injection Drug Product and Services
2.14.4 CordenPharma Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 CordenPharma Recent Developments/Updates
2.15 Pharmascience
2.15.1 Pharmascience Details
2.15.2 Pharmascience Major Business
2.15.3 Pharmascience Oncology Injection Drug Product and Services
2.15.4 Pharmascience Oncology Injection Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Pharmascience Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ONCOLOGY INJECTION DRUG BY MANUFACTURER
3.1 Global Oncology Injection Drug Sales Quantity by Manufacturer (2020-2025)
3.2 Global Oncology Injection Drug Revenue by Manufacturer (2020-2025)
3.3 Global Oncology Injection Drug Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Oncology Injection Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Oncology Injection Drug Manufacturer Market Share in 2024
3.4.3 Top 6 Oncology Injection Drug Manufacturer Market Share in 2024
3.5 Oncology Injection Drug Market: Overall Company Footprint Analysis
3.5.1 Oncology Injection Drug Market: Region Footprint
3.5.2 Oncology Injection Drug Market: Company Product Type Footprint
3.5.3 Oncology Injection Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oncology Injection Drug Market Size by Region
4.1.1 Global Oncology Injection Drug Sales Quantity by Region (2020-2031)
4.1.2 Global Oncology Injection Drug Consumption Value by Region (2020-2031)
4.1.3 Global Oncology Injection Drug Average Price by Region (2020-2031)
4.2 North America Oncology Injection Drug Consumption Value (2020-2031)
4.3 Europe Oncology Injection Drug Consumption Value (2020-2031)
4.4 Asia-Pacific Oncology Injection Drug Consumption Value (2020-2031)
4.5 South America Oncology Injection Drug Consumption Value (2020-2031)
4.6 Middle East & Africa Oncology Injection Drug Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Oncology Injection Drug Sales Quantity by Type (2020-2031)
5.2 Global Oncology Injection Drug Consumption Value by Type (2020-2031)
5.3 Global Oncology Injection Drug Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oncology Injection Drug Sales Quantity by Application (2020-2031)
6.2 Global Oncology Injection Drug Consumption Value by Application (2020-2031)
6.3 Global Oncology Injection Drug Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Oncology Injection Drug Sales Quantity by Type (2020-2031)
7.2 North America Oncology Injection Drug Sales Quantity by Application (2020-2031)
7.3 North America Oncology Injection Drug Market Size by Country
7.3.1 North America Oncology Injection Drug Sales Quantity by Country (2020-2031)
7.3.2 North America Oncology Injection Drug Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Oncology Injection Drug Sales Quantity by Type (2020-2031)
8.2 Europe Oncology Injection Drug Sales Quantity by Application (2020-2031)
8.3 Europe Oncology Injection Drug Market Size by Country
8.3.1 Europe Oncology Injection Drug Sales Quantity by Country (2020-2031)
8.3.2 Europe Oncology Injection Drug Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oncology Injection Drug Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Oncology Injection Drug Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Oncology Injection Drug Market Size by Region
9.3.1 Asia-Pacific Oncology Injection Drug Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Oncology Injection Drug Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Oncology Injection Drug Sales Quantity by Type (2020-2031)
10.2 South America Oncology Injection Drug Sales Quantity by Application (2020-2031)
10.3 South America Oncology Injection Drug Market Size by Country
10.3.1 South America Oncology Injection Drug Sales Quantity by Country (2020-2031)
10.3.2 South America Oncology Injection Drug Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oncology Injection Drug Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Oncology Injection Drug Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Oncology Injection Drug Market Size by Country
11.3.1 Middle East & Africa Oncology Injection Drug Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Oncology Injection Drug Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Oncology Injection Drug Market Drivers
12.2 Oncology Injection Drug Market Restraints
12.3 Oncology Injection Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oncology Injection Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncology Injection Drug
13.3 Oncology Injection Drug Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncology Injection Drug Typical Distributors
14.3 Oncology Injection Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Oncology Injection Drug Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oncology Injection Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3.Taj Oncology Basic Information, Manufacturing Base and Competitors
Table 4.Taj Oncology Major Business
Table 5.Taj Oncology Oncology Injection Drug Product and Services
Table 6.Taj Oncology Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7.Taj Oncology Recent Developments/Updates
Table 8. S.G. Biopharm Basic Information, Manufacturing Base and Competitors
Table 9. S.G. Biopharm Major Business
Table 10. S.G. Biopharm Oncology Injection Drug Product and Services
Table 11. S.G. Biopharm Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. S.G. Biopharm Recent Developments/Updates
Table 13. AdvaCare Basic Information, Manufacturing Base and Competitors
Table 14. AdvaCare Major Business
Table 15. AdvaCare Oncology Injection Drug Product and Services
Table 16. AdvaCare Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. AdvaCare Recent Developments/Updates
Table 18. Merrimack Basic Information, Manufacturing Base and Competitors
Table 19. Merrimack Major Business
Table 20. Merrimack Oncology Injection Drug Product and Services
Table 21. Merrimack Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merrimack Recent Developments/Updates
Table 23. Celgene Basic Information, Manufacturing Base and Competitors
Table 24. Celgene Major Business
Table 25. Celgene Oncology Injection Drug Product and Services
Table 26. Celgene Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Celgene Recent Developments/Updates
Table 28. AllosTherapeutics Basic Information, Manufacturing Base and Competitors
Table 29. AllosTherapeutics Major Business
Table 30. AllosTherapeutics Oncology Injection Drug Product and Services
Table 31. AllosTherapeutics Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. AllosTherapeutics Recent Developments/Updates
Table 33.Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34.Ferring Pharmaceuticals Major Business
Table 35.Ferring Pharmaceuticals Oncology Injection Drug Product and Services
Table 36.Ferring Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37.Ferring Pharmaceuticals Recent Developments/Updates
Table 38. Genzyme Basic Information, Manufacturing Base and Competitors
Table 39. Genzyme Major Business
Table 40. Genzyme Oncology Injection Drug Product and Services
Table 41. Genzyme Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Genzyme Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Oncology Injection Drug Product and Services
Table 46. Eli Lilly Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Praecis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Praecis Pharmaceuticals Major Business
Table 50. Praecis Pharmaceuticals Oncology Injection Drug Product and Services
Table 51. Praecis Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Praecis Pharmaceuticals Recent Developments/Updates
Table 53. Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Millennium Pharmaceuticals Major Business
Table 55. Millennium Pharmaceuticals Oncology Injection Drug Product and Services
Table 56. Millennium Pharmaceuticals Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Millennium Pharmaceuticals Recent Developments/Updates
Table 58. Debiopharm Basic Information, Manufacturing Base and Competitors
Table 59. Debiopharm Major Business
Table 60. Debiopharm Oncology Injection Drug Product and Services
Table 61. Debiopharm Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Debiopharm Recent Developments/Updates
Table 63. Alza Basic Information, Manufacturing Base and Competitors
Table 64. Alza Major Business
Table 65. Alza Oncology Injection Drug Product and Services
Table 66. Alza Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Alza Recent Developments/Updates
Table 68. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 69. CordenPharma Major Business
Table 70. CordenPharma Oncology Injection Drug Product and Services
Table 71. CordenPharma Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. CordenPharma Recent Developments/Updates
Table 73. Pharmascience Basic Information, Manufacturing Base and Competitors
Table 74. Pharmascience Major Business
Table 75. Pharmascience Oncology Injection Drug Product and Services
Table 76. Pharmascience Oncology Injection Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Pharmascience Recent Developments/Updates
Table 78. Global Oncology Injection Drug Sales Quantity by Manufacturer (2020-2025) & (K Pcs)
Table 79. Global Oncology Injection Drug Revenue by Manufacturer (2020-2025) & (USD Million)
Table 80. Global Oncology Injection Drug Average Price by Manufacturer (2020-2025) & (USD/Pcs)
Table 81. Market Position of Manufacturers in Oncology Injection Drug, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 82. Head Office and Oncology Injection Drug Production Site of Key Manufacturer
Table 83. Oncology Injection Drug Market: Company ProductTypeFootprint
Table 84. Oncology Injection Drug Market: Company Product ApplicationFootprint
Table 85. Oncology Injection Drug New Market Entrants and Barriers to Market Entry
Table 86. Oncology Injection Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Oncology Injection Drug Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 88. Global Oncology Injection Drug Sales Quantity by Region (2020-2025) & (K Pcs)
Table 89. Global Oncology Injection Drug Sales Quantity by Region (2026-2031) & (K Pcs)
Table 90. Global Oncology Injection Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 91. Global Oncology Injection Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 92. Global Oncology Injection Drug Average Price by Region (2020-2025) & (USD/Pcs)
Table 93. Global Oncology Injection Drug Average Price by Region (2026-2031) & (USD/Pcs)
Table 94. Global Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 95. Global Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 96. Global Oncology Injection Drug Consumption Value byType (2020-2025) & (USD Million)
Table 97. Global Oncology Injection Drug Consumption Value byType (2026-2031) & (USD Million)
Table 98. Global Oncology Injection Drug Average Price byType (2020-2025) & (USD/Pcs)
Table 99. Global Oncology Injection Drug Average Price byType (2026-2031) & (USD/Pcs)
Table 100. Global Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 101. Global Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 102. Global Oncology Injection Drug Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Global Oncology Injection Drug Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Global Oncology Injection Drug Average Price by Application (2020-2025) & (USD/Pcs)
Table 105. Global Oncology Injection Drug Average Price by Application (2026-2031) & (USD/Pcs)
Table 106. North America Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 107. North America Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 108. North America Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 109. North America Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 110. North America Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 111. North America Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 112. North America Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 113. North America Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 114. Europe Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 115. Europe Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 116. Europe Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 117. Europe Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 118. Europe Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 119. Europe Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 120. Europe Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 121. Europe Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Asia-Pacific Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 123. Asia-Pacific Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 124. Asia-Pacific Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 125. Asia-Pacific Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 126. Asia-Pacific Oncology Injection Drug Sales Quantity by Region (2020-2025) & (K Pcs)
Table 127. Asia-Pacific Oncology Injection Drug Sales Quantity by Region (2026-2031) & (K Pcs)
Table 128. Asia-Pacific Oncology Injection Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 129. Asia-Pacific Oncology Injection Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 130. South America Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 131. South America Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 132. South America Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 133. South America Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 134. South America Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 135. South America Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 136. South America Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 137. South America Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 138. Middle East & Africa Oncology Injection Drug Sales Quantity byType (2020-2025) & (K Pcs)
Table 139. Middle East & Africa Oncology Injection Drug Sales Quantity byType (2026-2031) & (K Pcs)
Table 140. Middle East & Africa Oncology Injection Drug Sales Quantity by Application (2020-2025) & (K Pcs)
Table 141. Middle East & Africa Oncology Injection Drug Sales Quantity by Application (2026-2031) & (K Pcs)
Table 142. Middle East & Africa Oncology Injection Drug Sales Quantity by Country (2020-2025) & (K Pcs)
Table 143. Middle East & Africa Oncology Injection Drug Sales Quantity by Country (2026-2031) & (K Pcs)
Table 144. Middle East & Africa Oncology Injection Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 145. Middle East & Africa Oncology Injection Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 146. Oncology Injection Drug Raw Material
Table 147. Key Manufacturers of Oncology Injection Drug Raw Materials
Table 148. Oncology Injection DrugTypical Distributors
Table 149. Oncology Injection DrugTypical Customers
LIST OFFIGURES
Figure 1. Oncology Injection Drug Picture
Figure 2. Global Oncology Injection Drug Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oncology Injection Drug Revenue Market Share byType in 2024
Figure 4. Organs Examples
Figure 5. Central Nervous System Examples
Figure 6. Circulatory/Musculoskeletal System Examples
Figure 7. Other Examples
Figure 8. Global Oncology Injection Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Oncology Injection Drug Revenue Market Share by Application in 2024
Figure 10. Lymphoma Examples
Figure 11. Myeloma Examples
Figure 12. Prostate Cancer Examples
Figure 13. Other Examples
Figure 14. Global Oncology Injection Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Oncology Injection Drug Consumption Value andForecast (2020-2031) & (USD Million)
Figure 16. Global Oncology Injection Drug Sales Quantity (2020-2031) & (K Pcs)
Figure 17. Global Oncology Injection Drug Price (2020-2031) & (USD/Pcs)
Figure 18. Global Oncology Injection Drug Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Oncology Injection Drug Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Oncology Injection Drug by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21.Top 3 Oncology Injection Drug Manufacturer (Revenue) Market Share in 2024
Figure 22.Top 6 Oncology Injection Drug Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Oncology Injection Drug Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Oncology Injection Drug Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 31. Global Oncology Injection Drug Consumption Value Market Share byType (2020-2031)
Figure 32. Global Oncology Injection Drug Average Price byType (2020-2031) & (USD/Pcs)
Figure 33. Global Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Oncology Injection Drug Revenue Market Share by Application (2020-2031)
Figure 35. Global Oncology Injection Drug Average Price by Application (2020-2031) & (USD/Pcs)
Figure 36. North America Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 37. North America Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 44. Europe Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 48.France Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 53. Asia-Pacific Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Oncology Injection Drug Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Oncology Injection Drug Consumption Value Market Share by Region (2020-2031)
Figure 56. China Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 59. India Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 63. South America Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Oncology Injection Drug Sales Quantity Market Share byType (2020-2031)
Figure 69. Middle East & Africa Oncology Injection Drug Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Oncology Injection Drug Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Oncology Injection Drug Consumption Value Market Share by Country (2020-2031)
Figure 72.Turkey Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Oncology Injection Drug Consumption Value (2020-2031) & (USD Million)
Figure 76. Oncology Injection Drug Market Drivers
Figure 77. Oncology Injection Drug Market Restraints
Figure 78. Oncology Injection Drug MarketTrends
Figure 79. PortersFiveForces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Oncology Injection Drug in 2024
Figure 81. Manufacturing Process Analysis of Oncology Injection Drug
Figure 82. Oncology Injection Drug Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
